TuisFBIOP • NASDAQ
add
Fortress Biotech 9 375 Cumulative Redeemable Perpetual Pref Shs Series A
Vorige sluiting
$5,18
Dagwisseling
$5,15 - $5,30
Jaarwisseling
$4,86 - $18,00
Markkapitalisasie
44,14 m USD
Gemiddelde volume
21,26 k
P/V-verhouding
-
Dividend-opbrengs
-
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 14,63 m | -7,13% |
Bedryfskoste | 21,99 m | 1,20% |
Netto inkomste | -12,87 m | -155,04% |
Netto winsgrens | -87,96 | -174,62% |
Wins per aandeel | -0,76 | 19,15% |
EBITDA | -21,14 m | 33,04% |
Effektiewe belastingkoers | -0,26% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 58,85 m | -18,61% |
Totale bates | 127,08 m | -15,59% |
Totale aanspreeklikheid | 139,82 m | -14,63% |
Totale ekwiteit | -12,74 m | — |
Uitstaande aandele | 27,60 m | — |
Prys om te bespreek | 6,73 | — |
Opbrengs op bates | -40,50% | — |
Opbrengs op kapitaal | -83,30% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | -12,87 m | -155,04% |
Kontant van bedrywe | -20,06 m | -19,55% |
Kontant van beleggings | — | — |
Kontant van finansiering | 2,71 m | 200,97% |
Netto kontantverandering | -17,35 m | -19,93% |
Beskikbare kontantvloei | -11,24 m | 25,59% |
Meer oor
Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida. Wikipedia
Gestig
2006
Webwerf
Werknemers
186
